Fahr Syndrome Secondary to Pseudohypoparathyroidism

dc.contributor.authorShu, Sharon W.
dc.contributor.authorSharma, Sakshi
dc.contributor.authorIqbal, Qasim Z.
dc.contributor.authorRomo, Karina G.
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2024-05-10T12:09:59Z
dc.date.available2024-05-10T12:09:59Z
dc.date.issued2023-12-01
dc.description.abstractFahr syndrome is a rare neurologic disorder, usually affecting young and middle-aged adults, that can present with symptoms ranging from extrapyramidal to neuropsychiatric abnormalities. Pseudohypoparathyroidism (PHP), characterized by parathyroid hormone (PTH)-resistance or PTH-unresponsiveness at target organs, is associated with Fahr syndrome and typically presents with hypocalcemia. The following case presents a 39-year-old-woman with PHP complicated by symptomatic hypocalcemia, hypokalemia, and movement disturbances, who had computed tomography imaging showing basal ganglia calcifications consistent with Fahr syndrome. She initially presented with headache and was hospitalized for hypertensive emergency and severe hypocalcemia. Examination, including the neurologic examination, was unrevealing aside from hypertension and central adiposity. Laboratory tests were consistent with PHP, showing hypocalcemia with elevated PTH, and negative for hyperaldosteronism. Management of hypocalcemia consisted of intravenous calcium infusion, oral calcium carbonate, oral vitamin D3, and oral calcitriol. Patients with severe hypocalcemia and elevated PTH who present with new neurological symptoms despite normal general neurologic examination may warrant consideration for brain imaging to evaluate for Fahr syndrome. Further investigations are necessary to determine the prevalence of Fahr syndrome and hypokalemia in patients with PHP, explore if these findings are significantly associated with PHP-1b subtype, and ultimately inform potential new screening pathways for these patients.
dc.eprint.versionFinal published version
dc.identifier.citationShu SW, Sharma S, Iqbal QZ, Romo KG. Fahr Syndrome Secondary to Pseudohypoparathyroidism. JCEM Case Rep. 2023;1(6):luad147. Published 2023 Dec 1. doi:10.1210/jcemcr/luad147
dc.identifier.urihttps://hdl.handle.net/1805/40640
dc.language.isoen_US
dc.publisherOxford University Press
dc.relation.isversionof10.1210/jcemcr/luad147
dc.relation.journalJCEM Case Reports
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.sourcePMC
dc.subjectFahr syndrome
dc.subjectPseudohypoparathyroidism
dc.subjectHypocalcemia
dc.subjectHypokalemia
dc.titleFahr Syndrome Secondary to Pseudohypoparathyroidism
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Shu2023FahrSyndrome-CCBY.pdf
Size:
191.66 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: